脑小血管病与房颤抗凝后缺血性卒中风险
本研究基于CROMIS-2前瞻性多中心队列,分析1419例因房颤抗凝的缺血性卒中或TIA患者,发现基线MRI脑小血管病标志物存在与随访期缺血性卒中风险独立相关(HR 1.89),且风险随SVD评分增加而升高。
要点
- 房颤抗凝后仍有缺血性卒中复发,脑小血管病标志物可帮助识别高风险患者。
- 存在任何SVD标志物者随访期缺血性卒中率为2.20/100患者年,无SVD者为0.98/100患者年。
- 调整CHA2DS2-VASc后,SVD存在与复发缺血性卒中独立相关(HR 1.89)。
核心结论
- 在因房颤抗凝的缺血性卒中或TIA患者中,MRI脑小血管病标志物与随访期缺血性卒中风险增加相关。
研究设计与样本
- 前瞻性多中心起始队列研究(CROMIS-2),纳入1419例因房颤抗凝的缺血性卒中或TIA患者,平均年龄75.8岁(SD 10.4),女性42.1%。
主要发现
- 存在任何SVD标志物的患者随访期缺血性卒中率为2.20/100患者年(95%CI 1.60-3.02),无SVD者为0.98/100患者年(95%CI 0.59-1.62),P=0.008。
- 调整CHA2DS2-VASc后,SVD存在与随访期缺血性卒中显著相关(HR 1.89,95%CI 1.01-3.53,P=0.046)。
- 复发缺血性卒中风险随SVD评分增加而升高(每增加1分HR 1.33,95%CI 1.04-1.70,P=0.023)。
关键数值与推荐
- SVD标志物包括:基底节血管周围间隙数量≥11、脑微出血数量≥1、腔隙灶数量≥1、脑白质高信号(脑室旁Fazekas 3级或深部白质Fazekas≥2级)。
- SVD存在定义为存在≥1个SVD标志物;SVD严重程度采用复合SVD评分。
临床怎么用
- 对房颤抗凝后缺血性卒中或TIA患者,可评估MRI脑小血管病标志物以辅助识别复发缺血性卒中高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The causes of recurrent ischemic stroke despite anticoagulation for atrial fibrillation are uncertain but might include small vessel occlusion. We investigated whether magnetic resonance imaging markers of cerebral small vessel disease (SVD) are associated with ischemic stroke risk during follow-up in patients anticoagulated for atrial fibrillation after recent ischemic stroke or transient ischemic attack. METHODS: We analyzed data from a prospective multicenter inception cohort study of ischemic stroke or transient ischemic attack anticoagulated for atrial fibrillation (CROMIS-2 [Clinical Relevance of Microbleeds in Stroke Study]). We rated markers of SVD on baseline brain magnetic resonance imaging: basal ganglia perivascular spaces (number ≥11); cerebral microbleeds (number ≥1); lacunes (number ≥1); and white matter hyperintensities (periventricular Fazekas grade 3 or deep white matter Fazekas grade ≥2). We investigated the associations of SVD presence (defined as presence of ≥1 SVD marker) and severity (composite SVD score) with the risk of ischemic stroke during follow-up using a Cox proportional hazards model adjusted for congestive heart failure, hypertension, age >75, diabetes, stroke, vascular disease, age 65-74, female score. RESULTS: We included 1419 patients (mean age: 75.8 years [SD, 10.4]; 42.1% female). The ischemic stroke rate during follow-up in patients with any SVD was 2.20 per 100-patient years (95% CI, 1.60-3.02), compared with 0.98 per 100 patient-years (95% CI, 0.59-1.62) in those without SVD (P=0.008). After adjusting for congestive heart failure, hypertension, age >75, diabetes, stroke, vascular disease, age 65-74, female score, SVD presence remained significantly associated with ischemic stroke during follow-up (hazard ratio, 1.89 [95% CI, 1.01-3.53]; P=0.046); the risk of recurrent ischemic stroke increased with SVD score (hazard ratio per point increase, 1.33 [95% CI, 1.04-1.70]; P=0.023). CONCLUSIONS: In patients anticoagulated for atrial fibrillation after ischemic stroke or transient ischemic attack, magnetic resonance imaging markers of SVD are associated with an increased risk of ischemic stroke during follow-up; improved stroke prevention treatments are required in this population. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02513316.
引用
- Du H, Wilson D, Ambler G, et al. Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia. Stroke. 2020. PMID: 33280548. doi:10.1161/STROKEAHA.120.029474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。